• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Percodan (oxycodone and aspirin) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2010


Summary View



Information for Patient/Caregivers
  • Patients should be advised that Percodan tablets may cause or worsen constipation, as generally occurs with all opioids. They should discuss any past history of constipation with their prescribing physician so a management plan may be initiated.